Articles from Proxim Diagnostics Corp.

Proxim Diagnostics Corp., an innovative company developing a handheld, point-of-care immunodiagnostic platform, announced that it has achieved a final development milestone for its Profile platform, including completion of the handheld reader, disposable cartridge, and initial manufacturing capacity.

Proxim Diagnostics Corp., an innovative company developing a handheld, point-of care diagnostic device, announced it has received a strategic investment from bioMérieux, a world leader in the field of in vitro diagnostics. The funds will be used to complete the development and commercial path for Proxim’s Profile System, a portable and fully automated immunodiagnostic device that can run a variety of multiplexed assays with disposable cartridges. As part of the investment, Andrew Parker, Senior Vice President and Head of Global Business Development for bioMérieux, has joined Proxim’s board of directors as an observer.